Cholangiocarcinoma tumorigenesis in Abcb4(Mdr2)-/- and wild-type mice by transposon-based oncogenes integration
RNA-seq (gene expression) · mouse · 24 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 24 samples: 24 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Transposon-based oncogene integration in Abcb4(Mdr2)(-/-) mice recapitulates high susceptibility to cholangiocarcinoma in primary sclerosing cholangitisJournal of hepatology · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE268905_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1119438 and SRA study SRP511359. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 24 sample titles: 24 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8302426 F1461_RNA_Seq
- GSM8302427 F1711_RNA_Seq
- GSM8302428 F1758_RNA_Seq
- GSM8302429 F2461_RNA_Seq
- GSM8302430 F2484_RNA_Seq
- GSM8302431 F2485_RNA_Seq
- GSM8302432 F1712_RNA_Seq
- GSM8302433 F1761_RNA_Seq
- GSM8302434 F1762_RNA_Seq
- GSM8302435 F1882_RNA_Seq
- GSM8302436 F2878_RNA_Seq
- GSM8302437 F2879_RNA_Seq
- GSM8302438 F2477_RNA_Seq
- GSM8302439 F2478_RNA_Seq
- GSM8302440 F2479_RNA_Seq
- GSM8302441 F2480_RNA_Seq
- GSM8302442 F3020_RNA_Seq
- GSM8302443 F3021_RNA_Seq
- GSM8302444 F1754_RNA_Seq
- GSM8302445 F1755_RNA_Seq
- GSM8302446 F1899_RNA_Seq
- GSM8302447 F1900_RNA_Seq
- GSM8302448 F1901_RNA_Seq
- GSM8302449 F2023_RNA_Seq
- GSE280057 Gene expression profile at single cell level of tumor-infiltrating neutrophils (TINs) of cholangiocarcinoma (CCA) tumors 52 samples shares cholangiocarcinoma
- GSE252380 Mouse extrahepatic cholangiocarcinoma study 17 samples shares cholangiocarcinoma
- GSE318390 Anticancer activity of RAS-GTP inhibition in cholangiocarcinoma [Mouse_hKPR.KPCHR_Sep25] 15 samples shares cholangiocarcinoma
- GSE308574 Macrophages display spatiotemporal specificity in intrahepatic cholangiocarcinoma and drive tumour progression via OSM and THBS1 12 samples shares cholangiocarcinoma
- GSE291359 Pbrm1 loss induces a permissive chromatin state for cholangiocytic differentiation and cholangiocarcinoma formation 12 samples shares cholangiocarcinoma
- GSE316440 Transcriptomic profiling of epigenetic regulators and metabolic reprogramming in human cholangiocarcinoma [liver] 12 samples shares cholangiocarcinoma
- GSE318389 Anticancer activity of RAS-GTP inhibition in cholangiocarcinoma [Mouse_iAKP_Abr24] 12 samples shares cholangiocarcinoma
- GSE270181 Identification of PRMT5 as a therapeutic target in cholangiocarcinoma [RNA-seq II] 9 samples shares cholangiocarcinoma
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.